These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
76 related articles for article (PubMed ID: 8941411)
1. PRaG Therapy of Refractory Metastatic Gastric Cancer: A Case Report. Xu H; Hong Z; Xu M; Kong Y; Ma Y; Shan C; Xing P; Zhang L Front Immunol; 2022; 13():926740. PubMed ID: 35874658 [TBL] [Abstract][Full Text] [Related]
2. Superior Therapeutic Efficacy of Nanoparticle Albumin Bound Paclitaxel Over Cremophor-Bound Paclitaxel in Experimental Esophageal Adenocarcinoma. Hassan MS; Awasthi N; Li J; Williams F; Schwarz MA; Schwarz RE; von Holzen U Transl Oncol; 2018 Apr; 11(2):426-435. PubMed ID: 29475139 [TBL] [Abstract][Full Text] [Related]
3. Phase II randomized trial of two nonoperative regimens of induction chemotherapy followed by chemoradiation in patients with localized carcinoma of the esophagus: RTOG 0113. Ajani JA; Winter K; Komaki R; Kelsen DP; Minsky BD; Liao Z; Bradley J; Fromm M; Hornback D; Willett CG J Clin Oncol; 2008 Oct; 26(28):4551-6. PubMed ID: 18574157 [TBL] [Abstract][Full Text] [Related]
4. Docetaxel in combination for advanced gastric cancer. Ajani JA Gastric Cancer; 2002; 5 Suppl 1():31-4. PubMed ID: 12772885 [TBL] [Abstract][Full Text] [Related]
5. The role of chemotherapy in the current treatment of gastric cancer. Van Cutsem E; Haller D; Ohtsu A Gastric Cancer; 2002; 5 Suppl 1():17-22. PubMed ID: 12772882 [TBL] [Abstract][Full Text] [Related]
6. Phase I study of a biweekly schedule of a fixed dose of cisplatin with increasing doses of paclitaxel in patients with advanced oesophageal cancer. van der Gaast A; Kok TC; Kerkhofs L; Siersema PD; Tilanus HW; Splinter TA Br J Cancer; 1999 Jun; 80(7):1052-7. PubMed ID: 10362115 [TBL] [Abstract][Full Text] [Related]
7. Paclitaxel in the treatment of metastatic breast cancer: M.D. Anderson Cancer Center experience. Buzdar AU; Holmes FA; Hortobagyi GN Semin Oncol; 1995 Jun; 22(3 Suppl 6):101-4. PubMed ID: 7541151 [TBL] [Abstract][Full Text] [Related]
8. Treatment of patients with upper gastrointestinal carcinomas. Ajani JA Semin Oncol; 1997 Dec; 24(6 Suppl 19):S19-72-S19-76. PubMed ID: 9427271 [TBL] [Abstract][Full Text] [Related]
9. The activity of paclitaxel in gastrointestinal tumors. Ajani JA; Ilson DH; Kelsen DP Semin Oncol; 1995 Oct; 22(5 Suppl 12):46-50; discussion 51-3. PubMed ID: 7481861 [TBL] [Abstract][Full Text] [Related]
10. Paclitaxel in the treatment of carcinoma of the esophagus. Ajani JA; Ilson DH; Daugherty K; Kelsen DP Semin Oncol; 1995 Jun; 22(3 Suppl 6):35-40. PubMed ID: 7541155 [TBL] [Abstract][Full Text] [Related]
11. A phase I/II study of paclitaxel plus cisplatin as first-line therapy for head and neck cancers: preliminary results. Hitt R; Hornedo J; Colomer R; Mendiola C; Brandariz A; Sevilla E; Alvarez-Vicent J; Cortés-Funes H Semin Oncol; 1995 Dec; 22(6 Suppl 15):50-4. PubMed ID: 8643971 [TBL] [Abstract][Full Text] [Related]
12. A phase II trial of paclitaxel and cisplatin in patients with advanced carcinoma of the esophagus. Ilson DH; Forastiere A; Arquette M; Costa F; Heelan R; Huang Y; Kelsen DP Cancer J; 2000; 6(5):316-23. PubMed ID: 11079171 [TBL] [Abstract][Full Text] [Related]
13. Paclitaxel in the treatment of patients with upper gastrointestinal carcinomas. Ajani JA; Ilson DH; Kelsen DP Semin Oncol; 1996 Oct; 23(5 Suppl 12):55-8. PubMed ID: 8941411 [TBL] [Abstract][Full Text] [Related]